DigestRedComo funciona
Red
/
Empresas
AC
No verificado

ACADIA Pharmaceuticals Inc.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

75 Comunicados de prensa

Ver todos los comunicados de prensa
30/04/2026
Mercado laboral
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
28/04/2026
Eventos
Web y redes sociales
Ciencia
Biotecnología
Farmacéutica
Salud
Psiquiatría
Medicina - Varios
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
17/04/2026
Eventos
Ferias y Congresos
Industria
Biotecnología
Sanidad
Salud
Farmacéutica
Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
15/04/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Biotecnología
Psiquiatría
Sanidad
Salud
Farmacéutica
Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
07/04/2026
Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
12/03/2026
Eventos
Web y redes sociales
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Psiquiatría
Medicina - Varios
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
03/03/2026
Mercado laboral
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
02/03/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Psiquiatría
Medicina - Varios
Acadia Pharmaceuticals Announces Plan to Request Re-Examination Following Negative CHMP Opinion for Trofinetide for the Treatment of Rett Syndrome
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
25/02/2026
Web y redes sociales
Telefonía
Mercado de valores
Psiquiatría
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
23/02/2026
Eventos
Web y redes sociales
Ciencia
Biotecnología
Farmacéutica
Salud
Psiquiatría
Medicina - Varios
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Fuente
ACADIA Pharmaceuticals Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0